Eder K, Kish S J, Kirchgessner M, Ross B M
Institute of Nutrition Physiology, Technical University of Munich, Germany.
Mov Disord. 1998 Sep;13(5):813-9. doi: 10.1002/mds.870130510.
Previous studies of patients with spinocerebellar atrophy type 1 (SCA-1) and Friedreich's ataxia (FA) have suggested the occurrence of membrane disturbances in both disorders. We measured concentrations of phosphatidylcholine (PC), diacyl and plasmalogen phosphatidylethanolamine (PE), and phosphatidylserine (PS), along with their fatty acid profiles, in the brains of eight patients with Friedreich's ataxia (FA) and nine patients with dominantly inherited spinocerebellar atrophy type 1 (SCA-1). Compared with the controls, levels of all phospholipid types (PE, PS, and PC) were reduced in the cerebellar but not occipital cortex of SCA-1 patients. In contrast, in the FA group, levels of PS and PE, but not PC, were reduced in both cerebellar and occipital cortices. The fatty acid composition of individual brain phospholipids was altered in both FA and SCA-1 patients, most markedly in the plasmalogen PE and PS classes of cerebellar phospholipids. Given the neuropathologic characteristics of each disorder, it is likely that altered fatty acid composition and phospholipid levels in SCA-1 cerebellar cortex occur as a consequence of pronounced cerebellar degeneration. In contrast, reduced phospholipid levels in FA cerebellar and occipital cortex, areas characterized by, at most, minimal neuronal loss in FA, may represent a widespread alteration in cellular phospholipid metabolism occurring in response to the specific gene defect in the disorder.
先前对1型脊髓小脑萎缩症(SCA - 1)和弗里德赖希共济失调(FA)患者的研究表明,这两种疾病均会出现膜功能紊乱。我们测定了8例弗里德赖希共济失调(FA)患者和9例显性遗传性1型脊髓小脑萎缩症(SCA - 1)患者大脑中磷脂酰胆碱(PC)、二酰基和缩醛磷脂酰乙醇胺(PE)以及磷脂酰丝氨酸(PS)的浓度,以及它们的脂肪酸谱。与对照组相比,SCA - 1患者小脑皮质中所有磷脂类型(PE、PS和PC)的水平均降低,但枕叶皮质未降低。相比之下,在FA组中,小脑和枕叶皮质中PS和PE的水平降低,但PC未降低。FA和SCA - 1患者大脑中各磷脂的脂肪酸组成均发生改变,最明显的是小脑磷脂中的缩醛磷脂PE和PS类别。鉴于每种疾病的神经病理学特征,SCA - 1小脑皮质中脂肪酸组成和磷脂水平的改变可能是明显的小脑变性的结果。相比之下,FA小脑和枕叶皮质中磷脂水平降低,而FA中这些区域最多只有极少的神经元丢失,这可能代表了针对该疾病特定基因缺陷而发生的细胞磷脂代谢的广泛改变。